Dark Streaming/Mobile Old Site Home Products Help Contact Us Your Account System Status
Sign-up for a FREE 30-day Stockwatch subscription and SEE NO ADS
01:15:27 EDT Thu 02 May 2024
Enter Symbol
or Name
USA
CA



News for U:TARA from 2023-05-03 to 2024-05-02 - 14 items News ReleasesIn The NewsOther CAUS
DateSymPriceTypeHeadline
2024-04-05 08:04U:TARANews ReleaseProtara Therapeutics Announces Oversubscribed $45 Million Private Placement Financing
2024-04-05 08:02U:TARANews ReleaseProtara Therapeutics Announces Alignment with FDA on Registrational Path Forward for IV Choline Chloride in Patients Dependent on Parenteral Nutrition
2024-04-05 08:00U:TARANews ReleaseProtara Therapeutics Announces Positive Three-Month Data from TARA-002 Clinical Program in NMIBC
2024-03-13 08:00U:TARANews ReleaseProtara Therapeutics Announces Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update
2024-02-28 08:00U:TARANews ReleaseProtara Therapeutics to Present at the TD Cowen 44th Annual Health Care Conference
2024-01-31 07:30U:TARANews ReleaseProtara Therapeutics to Participate in Upcoming Investor Conferences
2023-11-30 08:30U:TARANews ReleaseProtara Therapeutics Announces Presentation of Additional Encouraging Data from Phase 1a ADVANCED-1 Trial of TARA-002 in NMIBC at the 24th Annual Meeting of the Society of Urologic Oncology
2023-11-03 08:00U:TARANews ReleaseProtara Therapeutics Announces Third Quarter 2023 Financial Results and Business Update
2023-10-23 08:00U:TARANews ReleaseProtara Therapeutics Announces Dosing of First Patient in Phase 2 STARBORN-1 Trial of TARA-002 in Pediatric Patients with Lymphatic Malformations
2023-09-20 08:30U:TARANews ReleaseProtara Therapeutics Announces Dosing of First Patient in Phase 1b/2 ADVANCED-2 Trial of TARA-002 in NMIBC Patients with High Grade Carcinoma in Situ
2023-09-05 07:30U:TARANews ReleaseProtara Therapeutics to Present at the H.C. Wainwright 25th Annual Global Investment Conference
2023-08-03 08:00U:TARANews ReleaseProtara Therapeutics Announces Second Quarter 2023 Financial Results and Business Update
2023-05-15 08:00U:TARANews ReleaseProtara Therapeutics Announces Dosing of First Patients in Phase 1b ADVANCED-1EXP Trial of TARA-002 in NMIBC Patients with Carcinoma in Situ
2023-05-04 08:00U:TARANews ReleaseProtara Therapeutics Announces First Quarter 2023 Financial Results and Business Update